3 Canadian Growth Stocks to Buy and Hold Forever

Given their high-growth potential and discounted stock prices, these three growth stocks provide excellent entry points for long-term investors.

| More on:

Growth stocks will grow their financials above the industry average, thus delivering superior returns. Given their higher return potential, these companies trade at higher valuations. So, investors with higher risk-tolerance ability could buy these companies to earn substantial returns in the long run. Growth stocks have witnessed a considerable selloff over the last few months amid the expectation of multiple interest rate hikes.

However, the steep pullback has provided long-term investors an excellent buying opportunity in the following three stocks, given their high-growth potential.

goeasy

Over the last two decades, goeasy (TSX:GSY) has been delivering stellar performance, with its revenue and adjusted EPS growing at a CAGR of over 12% and 25%, respectively. Supported by these strong performances, the company has delivered impressive returns at a CAGR of above 39%. Despite its solid performance, the company has acquired only 1% of the sub-prime lending market. So, it has substantial growth potential.

The sub-prime lending market is highly fragmented. Given its expanded product range, new channel development ability, the addition of new business verticals, and geographical expansion initiatives, goeasy is well equipped to increase its market share in the coming years. The company’s management hopes to grow its loan portfolio by 80% over the next three years to reach $3.6 billion by 2024. Meanwhile, the management also expects to maintain its operating margin above 35% while delivering a return on equity of over 22%. So, goeasy’s growth prospects look healthy.

Meanwhile, goeasy has also rewarded its shareholders by raising its dividend at a CAGR of over 34% since 2014. So, considering all these factors, I believe goeasy would be an excellent addition to your portfolio.

Nuvei

Over the last six months, Nuvei (TSX:NVEI)(NASDAQ:NVEI) has lost over 50% of its stock value due to various reasons, including a short report from Spruce Capital Management, rising interest rates, higher valuations, and geopolitical tensions. However, the steep correction has provided an excellent buying opportunity, given its high-growth potential.

The pandemic has accelerated the adoption of online shopping, making digital transactions popular. This transition has created a long-term growth potential for Nuvei, which provides seamless digital transactions to merchants in over 200 markets worldwide. It also supports local and alternative payment technologies, including cryptocurrencies.

Further, the company also supports regulated online gaming and sports betting operators in over 10 states in the United States and Ontario. It also makes strategic acquisitions to drive growth. So, given its multiple growth drivers, I believe Nuvei is an excellent stock to buy at these levels.

Cargojet

My final pick is Cargojet (TSX:CJT), an air cargo company. Supported by a solid fleet of 29 aircraft, the company provides next-day delivery service to over 90% of the Canadian population, enjoying a competitive advantage over its peers. Its long-term customer contracts, high customer retention rate, and diversified revenue sources deliver stable and predictable financials.

With the growth in e-commerce, the demand for the company’s services is rising. So, the company has planned to increase its fleet and add new routes, which could boost its financials in the coming quarters. However, Cargojet currently trades at over 25% lower than its 52-week high amid the weakness in growth stocks. Its forward price-to-earnings multiple has declined to 24.3, which is lower than its historical average. So, I believe long-term investors should utilize this correction to accumulate the stock to earn substantial returns in the long run. 

The Motley Fool owns and recommends CARGOJET INC. and Nuvei Corporation. Fool contributor Rajiv Nanjapla has no position in any of the stocks mentioned.

More on Investing

diversification is an important part of building a stable portfolio
Tech Stocks

Undervalued Canadian Stocks to Buy Now

Markets are getting unruly and there are plenty of opportunities for contrarian investors. Here are two Canadian stocks that look…

Read more »

tsx today
Stock Market

TSX Today: What to Watch for in Stocks on Wednesday, February 4

Strength in energy and materials powered the TSX recovery on Tuesday, with investors’ focus shifting to U.S. jobs figures, PMI…

Read more »

Bitcoin
Tech Stocks

Here’s Why I Wouldn’t Touch This Meme Stock With a 10‑Foot Pole

Bitfarms can trade like a meme stock because the Bitcoin price and headlines drive it more than steady business fundamentals.

Read more »

TFSA (Tax-Free Savings Account) on wooden blocks and Canadian one hundred dollar bills.
Dividend Stocks

Trump Tariff Revival: 2 Bets to Help Your TFSA Ride Out the Storm

As tariff risks resurface and markets react, here are two safe Canadian stocks that could help protect your long-term TFSA…

Read more »

House models and one with REIT real estate investment trust.
Stocks for Beginners

2 Undervalued Bank Stocks and REITs Worth Buying in 2026

Undervalued banks and REITs can work in 2026, but only if earnings stay resilient and rate cuts actually help.

Read more »

Data center woman holding laptop
Tech Stocks

2 Overhyped Stocks That Could Turn $100,000 Into Nothing

Crypto-and-AI “theme” stocks can look inevitable in good markets, but they can break fast when sentiment or financing turns.

Read more »

Warning sign with the text "Trade war" in front of container ship
Dividend Stocks

This 5.2% Dividend Stock Is a Must-Buy as Trump Threatens Tariffs Again

With trade tensions back in focus, this 5.2% dividend stock offers income backed by real assets and long-term contracts.

Read more »

engineer at wind farm
Dividend Stocks

Canada’s Smart Money Is Piling Into This TSX Leader

Brookfield attracts “smart money” because it compounds through fees, real assets, and patient capital across market cycles.

Read more »